Transcriptomics Technologies Market
Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Press Release :
Global Transcriptomics Technologies Market: Snapshot
The global transcriptomics technologies market is expected to experience noteworthy growth in the forthcoming years. The growing interest of pharmaceutical companies in the development of targeted and personalized therapeutics is creating a demand for the identification of disease-specific biomarkers. This trend is contributing significantly to the growth of the market. Moreover, the increasing investments in the research and development activities along with the continual improvement in the healthcare infrastructure is providing a substantial boost to the growth of the market.
The future of the global transcriptomics technologies market looks bright with the rising focus on the development of bioinformatics tools and services. The increasing research and development activities are creating a pressing need among corporate, academic, and research institutes to develop sophisticated and reliable software to manage the plethora of research data. Hence, there are immense opportunities for both software and life science companies to develop advanced bioinformatics tools. Owing to all these factors, the opportunity in the global transcriptomics technologies market was pegged at US$2.55 bn in 2015 and is poised to expand at a CAGR of 15.9% between 2013 and 2019, reaching US$4.62 bn by 2019.
Polymerase Chain Reaction to Take a Dive of Success Owing to their High Process Efficiency
On the basis of technology, polymerase chain reaction (PCR) will continue to lead the market in terms of revenue until 2019. Benefits offered by PCR such as high process efficiency, better precision, and greater amplification are boosting its uptake. Moreover, wider application areas along with versatility in approach and incessant product modification are catalyzing the growth of the segment.
The next generation sequencing (NGS) segment is likely to tread along a healthy growth track, expanding at a CAGR greater than 19.0% during the forecast period. Factors such as rapid technological advancements enabling the analysis of cellular transcriptome from several dimensions, expanding application areas of NGS, and the increasing outsourcing of sequencing technologies are propelling the growth of the segment.
Based on applications, drug discovery and research was the dominant segment in terms of revenue in 2015 and will maintain its leadership until 2019. The rigorous research and development initiatives in the field of genomics and proteomics are boosting the adoption of transcriptomics technologies in drug discovery and research. The segment is expected to expand at a significant CAGR of 18.2% during the same period.
North America to Lead Due to Rigorous Research and Development Activities Coupled with Increasing Investments
Geographically, the global transcriptomics technologies market will continue to be dominated by North America until 2019. The region is primarily driven by the presence of numerous biotech companies with well-established infrastructure and advanced technological platforms. The increasing investment from private organizations for transcriptomics research is assisting companies in the region in developing targeted therapeutics. Moreover, the presence of various academic and research institutes pursuing transcriptome studies is fuelling the growth of the region. The region will command 39% in the overall market revenue by 2019.
Asia Pacific is estimated to exhibit a CAGR of 18.0% during the same period. The tremendous growth of the region can be attributed to the consistent growth in the research and development activities in the field of life sciences. The rising trend of outsourcing clinical research and medical research, particularly in India and China, is fuelling the advancements in life sciences, thereby promoting the growth of the transcriptomics technologies market in the region.
Europe and Rest of the World are expected to rise at the similar pace during the forecast horizon. The leading players in the market are Affymetrix Inc., Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina Inc., Life Technologies Corporation, and Thermo Fisher Scientific.
The report on the global transcriptomics technologies market bundles all factors that have influenced this market over the past few years and utilizes clear and effective processes and methodologies to ascertain the future of the global transcriptomics technologies market. The report states that the global transcriptomics technologies market is expected to expand handsomely over the next few years.
The global transcriptomics technologies market is divided in terms of technology, applications, and geography. The report then quantifies the leading segments according to each criterion in order to simplify the evaluation process of the global transcriptomics technologies market. This involves defining all market drivers and restraints that propel and hinder the global transcriptomics technologies market, respectively.
The key driving factor of the global transcriptomics technologies market is the growing requirement for all products in the market for personalized healthcare and comparison diagnostics. Other driving factors for the global transcriptomics technologies market include the availability of sufficient gear in laboratories as well as healthcare organizations, along with an increasing awareness of the benefits that transcriptomics technologies can bring to the healthcare sector.
The report explains key aspects that could affect the global transcriptomics technologies market in the coming few years.
The report utilizes proven research methods such as SWOT analysis and Porter’s five forces analysis to update the report’s user with the global transcriptomics technologies market’s determinant macro and micro factors as well as the value chain.
Overview of the Global Transcriptomics Technologies Market
The global transcriptomics technologies market is exhibiting a 15.90% CAGR from 2013 to 2019. The market was valued at US$1.65 bn in 2012. The consistent growth pattern of the market will lead to a value of US$4.6 bn for the global transcriptomics technologies market by the end of 2019.
The key segments of the global transcriptomics technologies market according to technology are gene regulation technologies, microarrays, PCR, and NGS. Transcriptomics technologies find major use in gene expression patterns and drug discovery. Transcriptomics technologies are also applied in the clinical diagnosis of central nervous system disorders, cardiovascular disorders, and cancers. Transcriptome analysis tools offer accurate insights into gene sequence identification, gene expression patterns, and gene regulation mechanisms.
The global transcriptomics technologies market could be restrained by factors such as the non-availability of resources and tools that help in analyzing critical and complex data, the lack of tools that allow for biology computation, and the overall lack of skilled manpower with domain expertise.
The global transcriptomics technologies market is led by Asia Pacific, which has the fastest growth rate, due to the sharply increasing population in the region, coupled with the consequent boost in supply by the vendor base in the region. North America is the largest regional segment of the global transcriptomics technologies market and held a revenue share of 35.0% in 2012.
Companies mentioned in the research report
The top players in the global transcriptomics technologies market are Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., and Life Technologies Corporation.
Key segments of the Global Transcriptomics Technologies Market
Transcriptomics Technologies Market, by Technology
- Polymerase Chain Reaction (PCR)
- Gene Regulation Technologies
- Next Generation Sequencing (NGS)
Transcriptomics Technologies Market, by Applications
- Clinical Diagnostics
- Drug Discovery and Research
- Comparative Transcriptomics Studies
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments